Update on the clinical management of diffuse large B-cell lymphoma
Christian Gisselbrecht et al.
Safety and efficacy of venetoclax plus LDAC in treatment-naive AML patients aged ≥ 65 years
The TAP CLARITY study: latest results and future plans
Current understandings of ALL approaches
Assaying FLT3 variant allele frequency in AML to determine response to treatment